We need a global system to help identify new uses for existing drugsBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1806 (Published 27 February 2014) Cite this as: BMJ 2014;348:g1806
- Ricardo Borges, professor of pharmacology and head of the pharmacology unit, University of La Laguna Medical School, The Unit of Pharmacology, E-38071 La Laguna, Tenerife, Spain
“Identification of potential therapeutic targets for new drugs” is a phrase commonly used in grant proposals in both basic and clinical research. Every year drug companies produce and patent hundreds of new drugs that have been assessed in preclinical tests. However, despite this enormous effort and cost, the number of new drugs in the formularies and available to clinicians is ever declining, and the general feeling is that this will persist.1
Many drugs are already used for therapeutic purposes that are different from those that were initially intended. Examples include the use of antidepressants as analgesics, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial